Bank of America
APRE icon

Bank of America’s Aprea Therapeutics APRE Stock Holding History

Bank of America’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,299
Closed -$2.81K – 5753
2025
Q4 		$2.81K Sell
3,299
-1,562
-32% -$1.92K ﹤0.01% 6364
2025
Q3 		$7.17K Buy
4,861
+5
+0.1% +$8 ﹤0.01% 7251
2025
Q2 		$8.21K Buy
4,856
+4
+0.1% +$7 ﹤0.01% 7226
2025
Q1 		$9.9K Buy
4,852
+1
+0% +$3 ﹤0.01% 7114
2024
Q4 		$16K Sell
4,851
-1
-0% -$3 ﹤0.01% 6889
2024
Q3 		$13.3K Sell
4,852
-1
-0% -$4 ﹤0.01% 6831
2024
Q2 		$19.8K Buy
4,853
+3,287
+210% +$16.9K ﹤0.01% 6743
2024
Q1 		$10.5K Sell
1,566
-1,685
-52% -$10.5K ﹤0.01% 6881
2023
Q4 		$15.3K Buy
3,251
+1
+0% +$4 ﹤0.01% 6850
2023
Q3 		$13.5K Buy
+3,250
New +$11.9K ﹤0.01% 6796
2023
Q2 		– Sell
-10
Closed -$44 – 7695
2023
Q1 		$44 Buy
10
+4
+67% +$30 ﹤0.01% 7524
2022
Q4 		$40 Buy
+6
New +$63 ﹤0.01% 7837
2022
Q3 		– Sell
-10
Closed – – 7805
2022
Q2 		$0 Sell
10
-199
-95% -$4.59K ﹤0.01% 7986
2022
Q1 		$8K Buy
209
+202
+2,886% +$8.28K ﹤0.01% 7784
2021
Q4 		$0 Sell
7
-508
-99% -$44.9K ﹤0.01% 8190
2021
Q3 		$53K Buy
515
+234
+83% +$21.3K ﹤0.01% 7016
2021
Q2 		$27K Sell
281
-169
-38% -$15.6K ﹤0.01% 7051
2021
Q1 		$46K Buy
450
+305
+210% +$35.6K ﹤0.01% 6660
2020
Q4 		$15K Sell
145
-4,157
-97% -$1.98M ﹤0.01% 6647
2020
Q3 		$2.07M Buy
4,302
+1,693
+65% +$947K ﹤0.01% 3652
2020
Q2 		$2.02M Sell
2,609
-50
-2% -$32.8K ﹤0.01% 3624
2020
Q1 		$1.85M Buy
2,659
+2,604
+4,735% +$1.91M ﹤0.01% 3546
2019
Q4 		$50K Buy
+55
New +$30.3K ﹤0.01% 6260

Other funds holding APRE

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America's APRE Position: Q1 2026 in Review

Bank of America sold out of Aprea Therapeutics (APRE) in Q1 2026, closing a stake of 3,299 shares — an estimated $2.81K sold.

Bank of America first reported a position in APRE in Q4 2019 and held it in 23 quarters. The position peaked at $2.07M in Q3 2020. 22 funds tracked by Wall St. Rank hold APRE as of Q1 2026.

  • Bank of America reported no remaining Aprea Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 3,299 Aprea Therapeutics shares in Q1 2026, an estimated $2.81K.
  • Bank of America first reported a position in Aprea Therapeutics in Q4 2019 and held it in 23 quarters.
  • Bank of America's Aprea Therapeutics position peaked at $2.07M in Q3 2020.
  • 22 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.